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Abstract 
 
Background:  While increases in obesity over the past 30 years have adversely affected 
population health, there have been concomitant improvements due to reductions in 
smoking. Better understanding of the joint effects of these trends on longevity and quality 
of life will help policymakers target resources more efficiently.    
Methods: For each year from 2005 to 2020, we forecast life expectancy and quality-
adjusted life expectancy for a representative 18 year old, assuming a continuation of past 
trends in smoking from the National Health Interview Survey (1978-79, 1990-91 and 2004-
06), and past trends in body-mass index (BMI) from the National Health and Nutrition 
Examination Survey (1971-75, 1998-1994, and 2003-06). The 2003 Medical Expenditure 
Panel Survey was used to examine the effects of smoking and BMI on health-related quality 
of life.  
Results: The negative effects of increasing BMI overwhelmed the positive effects of 
declines in smoking in multiple scenarios. In the base case, increases in the remaining life 
expectancy of a typical 18 year old are held back by 0.71 years or 0.91 quality-adjusted 
years between 2005 and 2020. If all U.S. adults became normal weight non-smokers by 
2020, LE is forecast to increase by 3.76 life years or 5.16 quality-adjusted years. 
Conclusions: If past obesity trends continue unchecked, the negative impact on U.S. population 
health is forecast to overtake the positive effect from declining smoking rates, which could erode 
the pattern of steady gains in health experienced since early in the 20
th century.   3 
INTRODUCTION 
 
Trends in behavioral risk factors can have a profound impact on population health.
1, 2 Estimates 
suggest that obesity accounts for 5 to 15% of deaths each year in the United States,
2-5 and 
smoking accounts for 18% each year.
1 Eliminating smoking could increase population life 
expectancy by as much as 1 to 2 years.
6, 7 In contrast, if obesity continues to grow at historical 
rates, a leveling off or even reversal of past life expectancy trends has been predicted.
8  
 
Beyond their impact on mortality, obesity and smoking also affect quality of life.
9-14 Smoking is 
a major risk factor for cardiovascular disease, chronic lung disease, and several cancers. Obesity 
leads to cardiovascular disease, diabetes, and joint problems.    
 
Recent U.S. trends in smoking and obesity have been in opposite directions; over the past fifteen 
years, smoking rates have declined by 20 percent, while obesity rates have increased by 48 
percent.
15 Estimating the joint impact of smoking and obesity trends on mortality and quality of 
life is important to yield a complete picture of their effects on population health. While previous 
studies have examined the joint effects of obesity and smoking on mortality, they have not used 
nationally representative data or examined quality of life. 
 
This study forecasts the impact of obesity and smoking trends on future U.S. life expectancy and 
quality-adjusted life expectancy. We use data from the past three decades to forecast future 
obesity and smoking rates, and estimate their joint impact on length and quality of life (QOL). 
   4 
METHODS   
 
Data Sources and Definitions 
Three surveys, each nationally representative of the civilian, non-institutionalized U.S. 
population,
16-19 were used to measure prevalence of risk factors and their impact on mortality and 
QOL in adults. 
 
Data on body mass index (BMI) were obtained from physical measures in the National Health 
and Nutrition Examination Survey (NHANES).
17 Respondents were classified using World 
Health Organization (WHO) criteria
20 as normal weight (BMI 18.5−24.9 kg/m
2), overweight 
(25.0−29.9 kg/m
2), obese (30.0−34.9 kg/m
2, obesity class I), or morbidly obese (≥35.0 kg/m
2, 
obesity classes II and III). Those with BMI <18.5 kg/m
2 were excluded because low BMI can be 
indicative of pre-existing illness.
21 To measure historical trends, mean BMI by 10-year age-
gender groups was calculated for four time periods: 1971-75 (NHANES I; N=4992),
22 1988-
1994 (NHANES III; N=17,689), 1999-2002 (first two waves of continuous NHANES; 
N=10,132), and 2003-2006 (two subsequent waves of continuous NHANES; N=10,436).   
  
Smoking trends were obtained from the National Health Interview Survey (NHIS).
18, 23 The 
population was divided into four groups: current smokers; former smokers who quit more than 
10 years prior; former smokers who quit within the prior 10 years; and never smokers. Smoking 
rates were examined by 10-year age-gender groups for four time windows: 1978-79 (N=23,488), 
1990-1991 (N=83,770), 1999-2001 (N=95,623) and 2004-2006 (N=86,069).  
   5 
The impacts of smoking and obesity on quality of life were estimated using the 2003 Medical 
Expenditure Panel Survey (MEPS),
16, 24 which included a self-rating of health on a scale from 
zero (worst health imaginable) to 100 (best).
25 Analyses included the 80% of respondents with 
complete data on smoking, obesity, and self-rated health (N=18,913).  
 
Risks of all-cause mortality for joint smoking/obesity categories were calculated using mortality 
follow-up data for NHANES I, II and III (combined N=24,758). Period life tables for the U.S. 
population were obtained from the National Center for Health Statistics (NCHS) and the Social 
Security Administration (for ages top coded in NHCS tables).
26, 27  
 
Forecasting Approach 
Our analysis proceeded in four parts. First, we forecasted future prevalence of smoking and 
obesity by simulating a continuation of past trends. Historical changes in smoking and BMI were 
calculated going back approximately 15 years. Respondents were divided into four smoking and 
four obesity categories, for 16 groups in total. To control for changing demographics, smoking 
and weight categories were weighted to 2000 national totals for each 10-year age-gender group.
28  
 
Using NHANES 2003-2006 as a baseline, we then forecasted the joint distribution of future 
smoking and obesity categories. An annual percentage increase in BMI consistent with historical 
change was simulated for each person. For smoking, we probabilistically assigned a percentage 
of current smokers to become former smokers and a percentage of current and short-term former 
smokers to become long-term quitters or non-smokers each year, to simulate a continuation of 
past rates of change. We then recalculated annual population shares in each of the 16   6 
BMI/smoking categories. Finally, for each future year we smoothed the population distribution 
by regressing an indicator for being in each BMI/smoking category on age and age squared.  
 
The second step was to estimate relative risks of all-cause mortality for each of the 
smoking/obesity categories using Cox proportional hazard models in combined NHANES I, II 
and III follow-up data. We used attained age as the time scale.
29 Covariates were baseline age in 
5-year intervals, gender, and race.  
 
The third step was to generate life tables for each smoking and BMI category. We began with 
age-specific mortality rates from 2004 life tables. Using the smoking-BMI relative risks of death 
and our estimates of smoking and BMI shares at each age, we calculated mortality rates at each 
age for each smoking-BMI category. These rates were used to simulate life expectancy (LE) for 
each smoking and BMI category.  
 
The impact of smoking and BMI on QOL was estimated using regression analysis
30 relating self-
rated health to smoking/obesity categories and sociodemographic variables. Because MEPS asks 
only about current smoking status, we assumed that QOL for former smokers was the same as 
that of never smokers. Predicted summary health scores were then estimated for each of the 
smoking/BMI categories by 10-year age groups. These quality of life scores were weighted by 
our population forecasts to estimate the effects of obesity and smoking on quality-adjusted life 
expectancy (QALE) for each future year.  
   7 
To estimate the impact these risk factors may already have had on life expectancy, we forecasted 
the change in life expectancy between 1990 and 2004, holding smoking and obesity rates 
constant at 1990 levels. We then compare the forecasted to the observed change in life 
expectancy over the interval. 
 
Sensitivity Analyses 
Our baseline simulation assumed a continuation of smoking and BMI trends through 2020 equal 
to the change over the previous 15 years. We formed alternate projections using historical 
changes from longer (30 year) and shorter (5 year) time windows. Also, because evidence 
suggests that the rate of obesity growth may be decelerating,
31, 32 we estimated the threshold rate 
of increase in BMI above which the adverse effects begin to surpass the beneficial effects of 
smoking declines. We also simulated the effects of eliminating smoking and reducing all BMI’s 
to normal (BMI < 25) by 2020. Finally, we performed sensitivity analyses using alternate relative 
risks of all cause mortality from two prospective studies of health professionals that, while not 
nationally representative, consider the joint effects of smoking and BMI.
21, 33  
 
RESULTS 
 
Historical smoking rates and mean BMI are shown in Table 1. On average, smoking declined by 
1.4 percent and BMI increased by 0.5 percent per year over the 15 years prior to 2005. Over the 
30 and 5 year historical windows, the annual rate of decline in smoking was higher (1.7% and 
2.0% per year, respectively), and the rate of increase in BMI was lower (0.4% and 0.3% per year, 
respectively).   8 
 
Assuming that historical 15-year trends continue through 2020, forecasted trends in the 
prevalence of smoking and distribution of BMI are shown in Figure 1 (smoothing details are 
given in the Appendix). Over the 15 year period, we project a 21% decline in current smoking, a 
44% decline in former smoking within 10 years, and a 5% increase in those quitting 10 or more 
years previously. Over that same time frame, the share of the population that is normal weight is 
projected to decline by 35%. Nearly half the population (45%) is forecast to be obese by 2020. 
 
Relative risks of all-cause mortality for the 16 smoking/BMI groups are shown in the Appendix. 
Mortality increased with current smoking and with greater weight, consistent with Flegal and 
colleagues’ findings.
3 Table 2 shows mean predicted QOL scores. Regression results are 
provided in the Appendix. Smokers had lower QOL than non-smokers at all ages, and QOL 
declined with increasing BMI across age groups.  
 
Fifteen year forecasts of life expectancy and QALE, accounting for changes in smoking alone, 
BMI alone, and both combined, are shown in the first row of Table 3 and in Figure 2 for a typical 
18 year old. By itself, continued declines in smoking at rates seen over the past 15 years would 
lead to an increase in LE of 0.31 years in addition to the trend in LE due to other factors and an 
increase in QALE of 0.41 years. In contrast, a continuation of increases in BMI would lead to 
health changes that are larger and in the opposite direction. Life expectancy would be reduced by 
1.02 years relative to trend and QALE by 1.32 years. The net effect of the two combined is a 
reduction of 0.71 in life expectancy relative to trend or 0.91 in QALE. This pattern of results is 
seen for all years between 2005 and 2020, and becomes more pronounced over time.  Sensitivity   9 
analyses using alternate mortality risks from prospective studies yielded similar results (Figure 
2c). 
 
Turning to historical trends, a typical 18 year old’s life expectancy increased by 2.44 years 
between 1990 and 2004.  This is in contrast to a forecasted life expectancy increase of 2.98 years 
had smoking and obesity rates remain unchanged from 1990 levels. Thus, adverse smoking and 
obesity trends reduced, but did not overwhelm, the impact of other factors over the 1990-2004 
period. The black lines in Figures 2 depict a continuation of the rate of increase not explained by 
changes in obesity and smoking.   
 
Table 3 summarizes the results of simulations using alternative forecasts of changes in smoking 
and BMI. Five and thirty year changes have slightly more rapid declines in smoking and less 
rapid increases in BMI.  However, even in these scenarios, the negative impact of increasing 
BMI surpassed the positive impact of falling smoking rates, eroding growth in both life 
expectancy and QALE. Indeed, there would be a negative effect on LE and QALE as long as the 
growth in BMI exceeds 0.15 percent per year (not shown). 
 
The hypothetical elimination of smoking by 2020 increased an 18 year old’s LE and QALE by 
1.73 and 2.17 years respectively, and returning the entire population to normal weight had 
similar effects. The combined effect of eliminating smoking and obesity was a net gain of 3.76 
life years or 5.16 quality-adjusted life years (table 3 and Figures 2a and 2b). 
 
DISCUSSION   10 
 
The negative effects of increasing obesity on U.S. population health are forecasted to surpass the 
benefits from continued reductions in smoking through the next decade. Further, these adverse 
health effects are forecasted to become larger over time. The magnitude is large. A 0.71 year 
reduction in life expectancy – our estimate of the combined impact of reduced smoking and 
increased obesity – is about one-quarter of the 2.98 year increase in life expectancy at age 18 that 
we forecast would have occurred between 1990 and 2004 without changes in these risk factors. 
Our results do not imply that life expectancy will fall; more likely, life expectancy will continue 
to rise but less rapidly than it otherwise would. 
 
The hypothetical scenario in which everyone is a normal weight non-smoker by 2020, though 
perhaps not achievable, illustrates the dramatic toll these behavioral risk factors can jointly take.  
Perfect risk factor control would add over 5 years of quality-adjusted life. 
 
Our forecasts suggest that a continuation of past trends would ultimately result in almost half the 
U.S. adult population meeting WHO criteria for obesity by 2020, a prediction consistent with 
Wang and colleagues.
34 That said, it is difficult to predict future smoking and obesity trends with 
accuracy. Risk factor trends are susceptible to policy and environmental factors, and there is 
evidence that BMI trends may be decelerating.
31, 32 However, increases in BMI among adults are 
likely to occur with the maturation of the current cohort of U.S. children, among whom obesity 
rates are at a historical high.
22 Further, in sensitivity analyses using different historical rates of 
change in risk factors, the negative effects of obesity trends continue to outweigh the positive 
effects of smoking declines as long as BMI increases exceed even minimal levels.     11 
  
While adverse behavioral risk factors cannot be completely eliminated, even modest weight 
loss
35 and reductions in smoking
12 can have substantial effects on population health. 
Research has demonstrated the clinical efficacy of several smoking cessation
36 and obesity
35, 37-39 
interventions.
36 The challenge is to increase their use
40 while continuing to develop and test other 
interventions. Effective public health and behavioral economics interventions are crucial for 
fostering continued smoking cessation efforts
41 and for combating the roots of obesity, which 
include sedentary lifestyles, widespread availability of high-calorie food in large portions, and 
reduced time for at-home food preparation.
32, 42-45 
 
As most of the ill health effects of obesity occur through chronic diseases, it is encouraging that 
control of cardiovascular disease risk factors such as high cholesterol and hypertension has 
improved over the past 40 years, particularly among those who are overweight and obese.
46  An 
important exception to this trend is diabetes,
46,47 which is at an all time high and continues to 
increase rapidly. Improved treatment of obesity-related diseases is thus vital to improving the 
nation’s health. 
 
Our study examined the joint impact of obesity and smoking trends on length and quality of life 
in the United States. A prior study estimated the impact of smoking and obesity trends on 
disability-adjusted life expectancy in the Netherlands.
48 The magnitude and direction of their 
findings were comparable to ours despite the marked difference in methods (they used a chronic 
disease microsimulation model). A strength of our study was the use of nationally representative   12 
data as a base for forecasts and underlying rates.  In projecting forward past co-occurring trends 
in both risk factors, we incorporate factors such as the weight gain among smokers who quit.
49 
 
Our study also has some limitations. While it quantifies the effects of obesity and smoking, it can 
not account for the many other factors that determine life expectancy and QOL, such as advances 
in medicine and public health. Historically, the positive impact of these factors has overwhelmed 
the effects of smoking and obesity; our results are depicted relative to an assumed continuation 
of this trend. There is ongoing debate about the impact of different BMI levels on mortality.
5, 50 
However, our relative risks of mortality come directly from nationally representative data and 
our findings are robust to sensitivity analyses using other published relative risks.
21, 48 Consistent 
with past studies,
3,4,21,33 mortality analyses did not include SES; alternate analyses controlling for 
education yielded very similar results (Table A3). Our quality of life estimates are cross-
sectional, which was required in order to measure the joint effects of smoking and obesity in a 
nationally representative sample. Comparison to a prospective study of QOL and weight loss 
suggests that actual quality changes associated with obesity may be greater than we estimate.
51.  
 
The forecasts reported are at a population level and do not apply to a particular person losing 
weight or quitting smoking. We also made some assumptions typical for population level 
estimates.
1-4, 8, 11 For example, we assume that risk increases instantaneously when a BMI 
threshold is crossed. However, because baseline risk is relatively low, actual increases in 
mortality are not observed right away. Further, while we simulate changes in smoking and BMI 
in each future year, our forecasts assume that once those levels are reached, they remain 
unchanged throughout an individual’s life. Finally, our analyses are not stratified by   13 
socioeconomic status.
8, 32, 52, 53 BMI has increased disproportionately for blacks, which may 
further heighten disparities in the future. 
 
The detrimental effect of increasing obesity on population health is tempered only somewhat by 
the decline in smoking. Efforts to improve health should focus on stabilization or reversal of 
BMI trends, continued reductions in tobacco use, and better control of clinical risk factors 
brought on by obesity and smoking. Inadequate progress in these areas could result in an erosion 
of the pattern of steady health gains experienced in the U.S. since the early 20
th century. 
Conclusion   14 
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Table 1: Historical Trends in Smoking Prevalence and Mean BMI Among U.S. Adults, 
1973−2005.  
 
  Historical Period  Annual Rate of Change 
  1973−79  1990  2000  2005  ~30 year ~15 year  ~5 year 
Current smokers  33.3%  25.7%  23.1%  20.9%  -1.7%  -1.4%  -2.0% 
Former smokers < 10 years  11.5%  12.7%  8.5%  7.5%   -1.6%  -3.6%  -2.4% 
Former smokers 10+ years  8.2%  12.6%  13.8%  13.1%   1.6%  0.3%  0.9% 
BMI (mean, kg/m
2)  25.2  26.5  27.9  28.3  0.4%  0.5%  0.3% 
 
Notes: All prevalence estimates and means are weighted by the age and gender distribution of 
the 2000 Census Population. Smoking data are from NHIS years that included questions on 
smoking, including time since quitting:1978-79, 1990-91, 1999-2001, and 2004-2006. Historical 
time periods covered for smoking are thus 26.5 years, 14.5 years, and 5 years. BMI data are from 
NHANES I (1971-1975), NHANES III (1988-1994), and continuous NHANES 1999-2002 and 
2003-2006. Using the mid-points of each of the time periods covered by these surveys, the 
historical time periods covered for BMI are 31.5 years, 13.5 years, and 4 years.   23 
Figure 1: Forecasted Distribution of Risk Factors, 2005-2020 
 
Panel A:  Smoking 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Panel B:  Body Mass Index 
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Table 2: Summary Quality of Life Scores by Risk Factor Level 
 
 
Former/Never Smokers 
Normal Weight 
 
Overweight  Obese  Morbidly Obese 
18-24  0.90  0.89  0.86  0.80 
25-34  0.88  0.88  0.84  0.78 
35-44  0.86  0.85  0.82  0.76 
45-54  0.84  0.84  0.80  0.75 
55-64  0.82  0.81  0.78  0.72 
65-74  0.78  0.77  0.74  0.68 
75+  0.72  0.71  0.68  0.64 
Current Smokers       
18-24  0.84  0.83  0.81  0.74 
25-34  0.82  0.81  0.78  0.72 
35-44  0.79  0.79  0.76  0.70 
45-54  0.78  0.77  0.74  0.69 
55-64  0.76  0.75  0.72  0.67 
65-74  0.72  0.71  0.66
*  0.61
* 
75+  0.67  0.67  0.66
*  0.61
* 
 
Note: Predicted Scores from Regression of EQ-5D Visual Analog Scale in MEPS 2003. 
*Because of small numbers, quality of life for obese and morbidly obese smokers was estimated 
jointly for everyone over age 65.   25 
Figure 2: Forecasted Life Expectancy and Quality-Adjusted Life Expectancy at age 18 from 
2005 to 2020, Considering Trends in Smoking Alone, BMI Alone, and Both Combined 
 
Panel A: Life Expectancy at Age 18 
 
*Returning the entire population to normal weight (BMI 18.5 – 25) and setting all current 
smokers to former smokers of 10+ years 
^ Continuation of the 1990 to 2004 rate of increase in LE independent of changes in obesity and 
smoking over that time period.   
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Panel B: Quality-Adjusted Life Expectancy at age 18 
 
*Returning the entire population to normal weight (BMI 18.5 – 25) and setting all current 
smokers to former smokers of 10+ years. 
^ Continuation of the 1990 to 2004 rate of increase in LE independent of changes in obesity and 
smoking over that time period.   
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Panel C: Comparison using Mortality Risks from Different Sources to Forecast Life Expectancy 
at Age 18 with Continued 15-year Trends in Smoking and Obesity  
 
Note: Comparison of forecasted continuation of 15-year smoking and obesity trends using 
relative risks of all-cause mortality from NHANES I, II and III (calculated in this study) and 
from two prospective studies (Freedman et al., 2006; Van Dam et al., 2008). For comparison to 
van Dam et al., new relative risks were calculated in NHANES combining obese and morbid 
obese categories. Note that the van Dam et al. relative risks were from a female sample (the 
Nurse’s Health Study). To obtain relative risks for joint smoking-obesity categories from this 
study, a multiplicative relationship between smoking and obesity was assumed. 
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Table 3: Impact of Alternate Assumptions About Smoking and BMI Trends on Life Expectancy 
and Quality Adjusted Life Expectancy at Age 18 
 
  Change from 2005 to 2020 
  Smoking 
Alone# 
BMI Alone*  Smoking and 
BMI 
Jointly~ 
Scenario: Simulated continuation of:    LE  QALE  LE  QALE  LE  QALE 
 Historical 15-year rate of change (baseline)  0.31  0.41  -1.02  -1.32  -0.71  -0.91 
 Historical 30 year rate of change  0.32  0.43  -0.76  -1.00  -0.43  -0.56 
 Historical 5 year rate of change   0.41  0.52  -0.58  -0.75  -0.10  -0.17 
 Everyone nonsmoking and/or normal weight^   1.73  2.17  1.40  2.44  3.76  5.16 
 
BMI= Body-Mass Index; LE= Life Expectancy; QALE= Quality Adjusted Life Expectancy 
 
#shows the impact of continuing trends in smoking while leaving BMI unaffected. 
*shows the impact of continuing trends in BMI while leaving smoking status unaffected.  
~shows the impact of continuing trends in both smoking and BMI 
^current smokers set to former smoker of 10+ years and all others set to nonsmokers. 
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Appendix 
 
This appendix provides additional information on the calculations in the paper, “Forecasting the 
Impact of Obesity and Smoking Trends on Future U.S. Quality-Adjusted Life Expectancy”.  For 
all statistical analyses, population weights appropriate to each of the three surveys were used,
16-19 
and analyses were performed using SAS
© software version 9.1 for UNIX
53 and Stata
© version 
10.
54 
 
Smoothing Smoking and Obesity by Age  
Table A1 shows the coefficient estimates used to predict the distribution of combined smoking 
and BMI categories in the NHANES 2003-2006 data. These regressions are used to smooth the 
rates in each cell by age.  Figure A1 shows an example of data at each age and the smooth trend 
for never smoking obese individuals.  
 
Table A1: Coefficients from 12 OLS Regressions Used to Predict the Distribution of Combined 
BMI and Smoking Categories, NHANES 2003-2006 
 
   Normal Weight  Overweight  Obese  Morbid Obese 
    beta  p-value  beta  p-value  beta  p-value  beta  p-value 
Never   Intercept  0.548  <.0001  0.178  <.0001  0.077  0.002  -0.027  0.214 
Smokers  Age  -0.015  <.0001  -0.000  0.758  0.001  0.229  0.005  <.0001 
  Age Squared  0.000  <.0001  0.000  0.751  -0.000  0.168  -0.000  <.0001 
                   
Former   Intercept  0.074  <.0001  0.028  0.019  -0.012  0.223  -0.018  0.022 
Smokers  Age  -0.002  <.0001  0.000  0.598  0.001  0.003  0.001  0.000 
< 10 years  Age Squared  0.000     .0001  0.000  0.582  0.000  0.002  0.000  0.000 
                   
Former   Intercept  0.001  0.966  -0.085  <.0001  -0.061  <.0001  -0.074  <.0001 
Smokers  Age  0.000  0.567  0.003  <.0001  0.003  <.0001  0.003  <.0001 
10+ years  Age Squared  0.000  0.000  0.000  0.986  0.000  0.055  0.000  <.0001 
                   
Current   Intercept  0.192  <.0001  0.052  0.015  0.024  0.143  0.006  0.678 
Smokers  Age  -0.002  0.044  0.002  0.007  0.002  0.023  0.002  0.005 
 Age Squared  0.000  0.986  0.000  <.0001  0.000  0.001  0.000  0.000 
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Categorization based on BMI (kilograms/meters
2): 18.5-<25 (normal weight/referent), 25-<30 
(over weight), 30-<35 (obese), 35+ (morbid obese). Current smokers and short and long-term 
former smokers were those who had ever smoked at least 100 cigarettes and who still smoked, 
had quit less than 10 years ago, or had quit 10 years or more, respectively. 
 
 
Figure A1: Rates of Obese Never Smokers by Age in NHANES 2003-2006 
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Mortality Relative Risks 
We estimate the relative risk of all-cause mortality using data from combined NHANES I, II, and 
III surveys, matched to subsequent death records. Table A2 shows the sample characteristics for 
the mortality data.   
 
Table A3 shows the Cox proportional hazards model for death by smoking-BMI cell.  Separate 
models were fit for deaths that occurred before and after age 60. Deaths in those age 60+ were 
right censored in the first model, and deaths under age 60 were left censored in the second. (The 
SAS entry= option was used with proc phreg.) Forty-three percent of the sample in our analyses 
attained age 60 or greater. Those lost to follow-up were assigned a survival time of ½ the 
possible survival interval before the time when they were lost, but were censored on mortality. 
Models also included race: white (including Hispanic), black, and other, and age in 5-year age 
groups (coefficients not shown). These analyses omit those who died within the first 4 years of 
follow-up. Alternate analyses not omitting any deaths did not yield appreciably different relative 
risks. 
  
Table A2: Sample Characteristics of NHANES I, II and III Data used for Mortality Analyses 
Ages 25-70  
 
  NHANES I  NHANES II  NHANES III 
Baseline Survey years  1971-1975  1976-190  1988-1994 
Year of mortality follow-up  1992  1992  2000 
Unweighted sample size*  5,959  7,578  11,221 
Number of deaths  -total 
                              -under age 60 
1,242 
  204 
1,145 
136 
    569 
    189 
 
*respondents age 25 to 70 at baseline with data on BMI and smoking in baseline interview 
excluding those underweight at baseline and deaths within the first 4 years of follow-up. 
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Table A3: Relative Risks of Death from all Causes among Respondents Aged 25-70 in NHANES 
I, II and III Combined 
 
Group 
Multivariate 
Hazard Ratio  95% CI 
Hazard Ratio 
Controlling for 
College Education 
  Attained age under 60        
  Normal weight never smokers  1.00  --  --  1.00 
  Overweight never smokers  0.86  0.44  1.68  0.86 
  Obese never smokers  1.10  0.62  1.98  1.09 
  Morbid obese never smokers 
  
2.73  1.54  4.82  2.66 
  Normal weight former smokers < 10 years  1.09  0.62  1.92  1.11 
  Overweight former smokers < 10 years  1.35  0.70  2.59  1.25 
  Obese former smokers < 10 years  1.31  0.53  3.22  1.25 
  Morbid obese former smokers < 10 years 
  
1.62  0.57  4.62  1.55 
  Normal weight former smokers 10+ years  0.51  0.19  1.33  0.51 
  Overweight former smokers 10+ years  0.74  0.34  1.62  0.74 
  Obese former smokers 10+ years  1.18  0.33  4.24  1.17 
  Morbid obese former smokers 10+ years 
  
1.47  0.39  5.54  1.44 
  Normal weight current smokers  2.10  1.39  3.18  2.02 
  Overweight current smokers  1.37  0.80  2.33  1.31 
  Obese current smokers  2.39  1.23  4.65  2.32 
  Morbid obese current smokers  3.95  2.00  7.79  3.74 
  
Attained age 60 or over  
       
  Normal weight never smokers  1.00  --  --  1.00 
  Overweight never smokers  0.84  0.68  1.05  0.83 
  Obese never smokers  1.11  0.87  1.43  1.10 
  Morbid obese never smokers 
   
1.68  1.28  2.21  1.63 
  Normal weight former smokers < 10 years  1.48  1.15  1.92  1.50 
  Overweight former smokers < 10 years  1.39  1.10  1.75  1.34 
  Obese former smokers < 10 years  1.51  1.04  2.19  1.47 
  Morbid obese former smokers < 10 years 
  
1.42  0.78  2.59  1.41 
  Normal weight former smokers 10+ years  0.85  0.64  1.13  0.86 
  Overweight former smokers 10+ years  1.08  0.85  1.37  1.08 
  Obese former smokers 10+ years  1.32  0.96  1.82  1.30 
  Morbid obese former smokers 10+ years 
  
1.92  1.10  3.37  1.90 
  Normal weight current smokers  2.30  1.93  2.75  2.25 
  Overweight current smokers  1.99  1.58  2.50  1.94 
  Obese current smokers  3.03  2.31  3.96  2.94 
  Morbid obese current smokers  4.04  3.29  5.89  4.28   33 
Categorization based on BMI (kilograms/meters
2): 18.5-<25 (normal weight/referent), 25-<30 
(over weight), 30-<35 (obese), 35+ (morbid obese). Current smokers and short and long-term 
former smokers were those who had ever smoked at least 100 cigarettes and who still smoked, 
had quit less than 10 years ago, or had quit 10 years or more, respectively.   
In combining the three waves of NHANES, sampling weights from each individual survey were 
used. Weights specific to follow-up were required for NHANES I;
55 baseline weights were used 
for NHANES II and III. Strata variables from the three surveys were considered independent.  
Alternate analyses that weighted the sampling weights from each wave of NHANES by the 
sample size in that wave yielded very similar results.   
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 Measuring Quality of Life 
 
Table A4 shows the predictions of quality of life by smoking and obesity status.  Predicted 
summary health scores are calculated by 10-year age groups for smokers and nonsmokers and for 
each of the 4 weight categories. Predicted scores are treated as disutilities (decrements to health 
on a 0-1 scale on which 1 and 0 are equal to perfect health and death, respectively). Utilities 
(quality of life scores) for each group are obtained by subtracting predicted disutilities from 1. 
Our weights are derived from a 100-point visual analog rating scale, which typically yields lower 
utilities than standard gamble or time-tradeoff methods. However, it was the differences across 
groups that were more important to our forecasts than the absolute values. 
 
Table A4: Multivariate Linear Regression of 100-Point Self Rating of Health (transformed to a 
0-1 scale) on Smoking, Obesity, and Sociodemographic Variables in MEPS 2003  
Covariates 
Population 
percent  beta  p-value 
Current smoker  22.1  -0.053  <.0001 
BMI (kilograms/meters
2)       
  18.5-<25 (normal weight/referent) 
  25-<30 (over weight) 
  30-<35 (obese) 
  35+ (morbid obese) 
37.8 
36.5 
16.1 
 9.5 
-- 
-0.008 
-0.039 
-0.090 
-- 
0.0012 
<.0001 
<.0001 
Age and Gender       
  Age    -0.007  <.0001 
  Age squared    0.000  0.0053 
  Age cubed    0.000  0.0033 
  Male  48.7  0.044  <.0001 
  Age x Male    -0.001  <.0001 
Race/Ethnicity       
  Black  10.7  0.003  0.5948 
  Non-White Other   5.8  -0.025  <.0001 
Income (relative to 400% of poverty and above)       
  < 100% poverty  10.5  -0.098  <.0001 
  100-<125% poverty   4.0  -0.075  <.0001 
  125-<200% poverty  13.1  -0.055  <.0001 
  200-<400% poverty  30.4  -0.027  <.0001 
  400% poverty and over (referent)  42.1  --  --   35 
Covariates 
Population 
percent  beta  p-value 
Intercept    1.028  <.0001 
Summary statistics     
    N    18,530 
    R
2    0.160 
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